Guanhao Biology (300238.SZ): Does not involve synthetic biology business or related research

Gelonghui May 9 丨 Guanhao Biology (300238.SZ) announced the stock price change announcement. The company paid attention to some media, stock bars and other platforms to discuss synthetic biology and related hot concepts. Currently, the company is not involved in synthetic biology business or related research.

Gelonghui FinanceMay 9 04:34 ET

Guanhao Biology (300238.SZ): The core business is the three major business segments of materials, pharmaceuticals, and cells

Gelonghui, May 8 | Guanhao Biology (300238.SZ) said on the investor interactive platform that the company's core business is the three major business segments: materials, pharmaceuticals, and cells. The main products in the field of materials include biotype dural (spine) membrane patches, B-type cerebral (spine) membrane patches, thoracic surgical repair films, sterile biological wound protection films, and Ario breast patches, which can be widely used in neurosurgery, thoracic surgery, dermatology, orthopedics, plastic surgery, etc. Benvermide, the main product in the pharmaceutical industry, can treat inflammatory and autoimmune diseases such as psoriasis and atopic dermatitis. The cell field mainly includes cell storage and cellular cartilage treatment

Gelonghui FinanceMay 8 04:20 ET

Guan Hao Biology (300238.SZ): Currently, the company is not involved in synthetic biology-related research

Gelonghui May 8 丨 Guanhao Biology (300238.SZ) said on the investor interactive platform that currently the company is not involved in synthetic biology-related research.

Gelonghui FinanceMay 8 04:19 ET

The controlling shareholder of Guanhao Biology (300238.SZ) pledges 14.65 million shares

Guanhao Biology (300238.SZ) announced that the company recently received Guangdong Zhiguang Biotechnology Co., Ltd., the controlling shareholder of the company...

Zhitong FinanceApr 10 04:44 ET

Guanhao Biology (300238.SZ): As of March 20, 2024, the total number of shareholders of the company was 31,042

Gelonghui March 21丨Guanhao Biotech (300238.SZ) said on the investor interactive platform that as of March 20, 2024, the total number of shareholders of the company was 31,042.

Gelonghui FinanceMar 21 03:50 ET

Optimistic Investors Push Guanhao Biotech Co.,Ltd. (SZSE:300238) Shares Up 26% But Growth Is Lacking

Those holding Guanhao Biotech Co.,Ltd. (SZSE:300238) shares would be relieved that the share price has rebounded 26% in the last thirty days, but it needs to keep going to repair the recent damage it

Simply Wall StMar 18 20:33 ET